Purchase Order 75N93023P00835

Award Date 7/20/23
Potential Completion Date 7/19/24
Potential Value $215K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02454, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $230,978.00 firm fixed price purchase order to Nova Biomedical Corp for NOVA Biomedical consumables for the NOVA Flex 2 blood gas analyzer. The award originates from a simplified acquisition procedure solicitation issued by the Vaccine Production Program of the Vaccine Research Center (VRC) of NIAID, which sought the supplies without a small business...
The U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Nova Biomedical Corp, a manufacturer of advanced critical care blood gas analyzers, testing meters, and in-vitro diagnostic equipment. The $164,144 contract is for the delivery of various medical consumables over the period ending September 15, 2022. The award resulted from a brand name-restricted, full...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $576,000 firm fixed price purchase order to Nova Biomedical Corporation of Waltham, Massachusetts. The contract calls for COVID-19 related equipment including five BioProfile FLEX2 modules to support the agency's coronavirus response efforts. Performance will occur in Waltham through July 2020. No set aside designation or subcontractors were indicated. This...
The U.S. Department of Health and Human Services (HHS) awarded a $54,600 firm-fixed-price purchase order to Nova Biomedical Corp, a manufacturer of medical equipment and diagnostics based in Waltham, Massachusetts. The contract is for the provision of FDA-approved Nova Biomedical glucose testing systems to the NIH Clinical Center in Bethesda, Maryland. The award has an ultimate completion date of September 21, 2023 and is not designated as a set-aside contract. Nova Biomedical has an extensive...
The U.S. Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price purchase order contract to Nova Biomedical Corp, a manufacturer of advanced medical diagnostic equipment and supplies. The $73,777.00 contract is for the delivery of Nova BioProfile FLEX 1 and Nova BioProfile 2 devices. This award is not set aside. Nova Biomedical Corp has an extensive history of providing a wide range of medical equipment, reagents, and consumables to various federal...
The U.S. government awarded a $23,700.00 firm fixed-price purchase order contract to Nova Biomedical Corp, a leading manufacturer of advanced critical care medical equipment and in-vitro diagnostic devices. The contract, which does not have a set-aside designation, is to provide medical supplies to the Bureau of Administration, a civilian federal agency. The award has an ultimate completion date of June 15, 2024. Nova Biomedical Corp is a large, privately-owned company headquartered in...
This is a $16,900 firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian federal agency, to Nova Biomedical Corp, a leading manufacturer of advanced medical equipment and diagnostic devices. The contract is for the provision of medical supplies with a period of performance through March 26, 2025. Nova Biomedical, a large, privately-owned company headquartered in Waltham, Massachusetts, has a long history of supplying critical medical equipment and...
This is a $23,700.00 firm fixed price purchase order awarded by the Bureau of Administration, a civilian federal agency, to Nova Biomedical Corporation, a leading manufacturer of advanced critical care medical equipment and in-vitro diagnostic devices. The contract is for the delivery of unspecified medical supplies, with a period of performance through May 22, 2024. No set-aside designation was used. Nova Biomedical has an extensive history of federal contract awards, including providing...
This is a firm fixed-price purchase order awarded by the Bureau of Administration, a civilian federal agency, to Nova Biomedical Corp, a leading manufacturer of advanced medical equipment and diagnostic devices. The $15,458.00 contract is for the provision of medical supplies with a completion date of May 22, 2024. The award is not set aside for any special business category. Nova Biomedical is a large, privately-owned company that has a significant track record of providing critical medical...
This federal contract award to Nova Biomedical Corp, a leading manufacturer of advanced critical care medical equipment and in-vitro diagnostic devices, is for the provision of medical supplies. The contract, valued at $23,700.00, is a firm-fixed-price purchase order awarded by the Bureau of Administration, a civilian agency. There is no set-aside designation for this award. Nova Biomedical has a significant Blanket Purchase Agreement (BPA) valued at $109,261.80 with the Department of Veterans...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $214,788 firm fixed price purchase order to Nova Biomedical Corporation of Waltham, Massachusetts. The contract is for NOVA Biomedical consumables for the NOVA Flex 2 analytical laboratory instrument, as described in the attached bill of materials, to support the Vaccine Production Program of the Vaccine Research Center. Delivery of the products will occur in four shipments between July 2023 and April 2024 to the NIAID facility in Gaithersburg, Maryland. The award resulted from simplified acquisition procedures solicitation number RFQ-NIAID-23-2176802 and has no designated set aside.

Generated 12/24/23, 4:14 PM